BLOOD-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=554361, encodeId=942c554361c2, content=谢谢你老师.已经>30了.估计快了匿名的东风 2018-03-22 发表:: 一审大概30天左右匿名的东风 2018-03-22 00:00:00 发表: 一审大概30天左右, beContent=匿名的东风 2018-03-22 发表:: 一审大概30天左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Sat Mar 31 00:00:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554042, encodeId=2fc8554042e0, content=一审大概30天左右Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, beContent=Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Thu Mar 22 00:00:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552630, encodeId=3013552630cd, content=一审快不快?怕抢发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547260, encodeId=a37f54e26079, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, beContent=alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547259, encodeId=e0c154e259bf, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., beContent=WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546379, encodeId=1e545463e9d6, content=收费吗?怎么个收费原则?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Wed Sep 06 09:08:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538033, encodeId=4e315380339c, content=13.16 血液病还是这个是标杆，没有开源杂志抢稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71a098094, createdName=qsqsqsqs12, createdTime=Fri Jun 16 00:37:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835346, encodeId=13f183534695, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：美国血液学会发表的医学周刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee5414068, createdName=ms7442275544109079, createdTime=Fri Jan 20 10:36:08 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529215, encodeId=55f352921539, content=11.3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Fri Nov 11 10:28:00 CST 2016, time=2016-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834476, encodeId=54bb8344e626, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：录用率那么低的，每次投稿还要交50美金审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Mon Nov 07 09:31:52 CST 2016, time=2016-11-07, status=1, ipAttribution=)]

2018-03-31 Dr. H

谢谢你老师.已经>30了.估计快了匿名的东风 2018-03-22 发表::
一审大概30天左右匿名的东风 2018-03-22 00:00:00 发表:
一审大概30天左右

匿名的东风 2018-03-22 发表:: 一审大概30天左右

466 0

[GetPortalCommentsPageByObjectIdResponse(id=554361, encodeId=942c554361c2, content=谢谢你老师.已经>30了.估计快了匿名的东风 2018-03-22 发表:: 一审大概30天左右匿名的东风 2018-03-22 00:00:00 发表: 一审大概30天左右, beContent=匿名的东风 2018-03-22 发表:: 一审大概30天左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Sat Mar 31 00:00:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554042, encodeId=2fc8554042e0, content=一审大概30天左右Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, beContent=Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Thu Mar 22 00:00:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552630, encodeId=3013552630cd, content=一审快不快?怕抢发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547260, encodeId=a37f54e26079, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, beContent=alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547259, encodeId=e0c154e259bf, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., beContent=WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546379, encodeId=1e545463e9d6, content=收费吗?怎么个收费原则?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Wed Sep 06 09:08:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538033, encodeId=4e315380339c, content=13.16 血液病还是这个是标杆，没有开源杂志抢稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71a098094, createdName=qsqsqsqs12, createdTime=Fri Jun 16 00:37:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835346, encodeId=13f183534695, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：美国血液学会发表的医学周刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee5414068, createdName=ms7442275544109079, createdTime=Fri Jan 20 10:36:08 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529215, encodeId=55f352921539, content=11.3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Fri Nov 11 10:28:00 CST 2016, time=2016-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834476, encodeId=54bb8344e626, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：录用率那么低的，每次投稿还要交50美金审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Mon Nov 07 09:31:52 CST 2016, time=2016-11-07, status=1, ipAttribution=)]

2018-03-22 匿名的东风

一审大概30天左右Dr. H 2018-02-12 00:00:00 发表:
一审快不快?怕抢发

Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发

421 0

[GetPortalCommentsPageByObjectIdResponse(id=554361, encodeId=942c554361c2, content=谢谢你老师.已经>30了.估计快了匿名的东风 2018-03-22 发表:: 一审大概30天左右匿名的东风 2018-03-22 00:00:00 发表: 一审大概30天左右, beContent=匿名的东风 2018-03-22 发表:: 一审大概30天左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Sat Mar 31 00:00:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554042, encodeId=2fc8554042e0, content=一审大概30天左右Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, beContent=Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Thu Mar 22 00:00:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552630, encodeId=3013552630cd, content=一审快不快?怕抢发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547260, encodeId=a37f54e26079, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, beContent=alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547259, encodeId=e0c154e259bf, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., beContent=WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546379, encodeId=1e545463e9d6, content=收费吗?怎么个收费原则?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Wed Sep 06 09:08:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538033, encodeId=4e315380339c, content=13.16 血液病还是这个是标杆，没有开源杂志抢稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71a098094, createdName=qsqsqsqs12, createdTime=Fri Jun 16 00:37:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835346, encodeId=13f183534695, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：美国血液学会发表的医学周刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee5414068, createdName=ms7442275544109079, createdTime=Fri Jan 20 10:36:08 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529215, encodeId=55f352921539, content=11.3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Fri Nov 11 10:28:00 CST 2016, time=2016-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834476, encodeId=54bb8344e626, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：录用率那么低的，每次投稿还要交50美金审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Mon Nov 07 09:31:52 CST 2016, time=2016-11-07, status=1, ipAttribution=)]

2018-02-12 Dr. H

一审快不快?怕抢发

557 0

[GetPortalCommentsPageByObjectIdResponse(id=554361, encodeId=942c554361c2, content=谢谢你老师.已经>30了.估计快了匿名的东风 2018-03-22 发表:: 一审大概30天左右匿名的东风 2018-03-22 00:00:00 发表: 一审大概30天左右, beContent=匿名的东风 2018-03-22 发表:: 一审大概30天左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Sat Mar 31 00:00:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554042, encodeId=2fc8554042e0, content=一审大概30天左右Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, beContent=Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Thu Mar 22 00:00:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552630, encodeId=3013552630cd, content=一审快不快?怕抢发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547260, encodeId=a37f54e26079, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, beContent=alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547259, encodeId=e0c154e259bf, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., beContent=WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546379, encodeId=1e545463e9d6, content=收费吗?怎么个收费原则?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Wed Sep 06 09:08:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538033, encodeId=4e315380339c, content=13.16 血液病还是这个是标杆，没有开源杂志抢稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71a098094, createdName=qsqsqsqs12, createdTime=Fri Jun 16 00:37:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835346, encodeId=13f183534695, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：美国血液学会发表的医学周刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee5414068, createdName=ms7442275544109079, createdTime=Fri Jan 20 10:36:08 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529215, encodeId=55f352921539, content=11.3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Fri Nov 11 10:28:00 CST 2016, time=2016-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834476, encodeId=54bb8344e626, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：录用率那么低的，每次投稿还要交50美金审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Mon Nov 07 09:31:52 CST 2016, time=2016-11-07, status=1, ipAttribution=)]

2017-09-16 匿名的东风

请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!alansb 2012-08-26 08:00:00 发表:
今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间!

Submission date: 22 Mar 2012
Major Revision: 7 May 2012
Revision received: 12 Jul 2012
Minor Revision: 14 Aug 2012
Revision received: 20 Aug 2012
Accepted: 24 Aug 2012

谢谢对大家的支持和努力!再接再厉做好科研!

alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间!

Submission date: 22 Mar 2012
Major Revision: 7 May 2012
Revision received: 12 Jul 2012
Minor Revision: 14 Aug 2012
Revision received: 20 Aug 2012
Accepted: 24 Aug 2012

谢谢对大家的支持和努力!再接再厉做好科研!

480 0

[GetPortalCommentsPageByObjectIdResponse(id=554361, encodeId=942c554361c2, content=谢谢你老师.已经>30了.估计快了匿名的东风 2018-03-22 发表:: 一审大概30天左右匿名的东风 2018-03-22 00:00:00 发表: 一审大概30天左右, beContent=匿名的东风 2018-03-22 发表:: 一审大概30天左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Sat Mar 31 00:00:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554042, encodeId=2fc8554042e0, content=一审大概30天左右Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, beContent=Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Thu Mar 22 00:00:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552630, encodeId=3013552630cd, content=一审快不快?怕抢发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547260, encodeId=a37f54e26079, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, beContent=alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547259, encodeId=e0c154e259bf, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., beContent=WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546379, encodeId=1e545463e9d6, content=收费吗?怎么个收费原则?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Wed Sep 06 09:08:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538033, encodeId=4e315380339c, content=13.16 血液病还是这个是标杆，没有开源杂志抢稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71a098094, createdName=qsqsqsqs12, createdTime=Fri Jun 16 00:37:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835346, encodeId=13f183534695, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：美国血液学会发表的医学周刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee5414068, createdName=ms7442275544109079, createdTime=Fri Jan 20 10:36:08 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529215, encodeId=55f352921539, content=11.3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Fri Nov 11 10:28:00 CST 2016, time=2016-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834476, encodeId=54bb8344e626, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：录用率那么低的，每次投稿还要交50美金审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Mon Nov 07 09:31:52 CST 2016, time=2016-11-07, status=1, ipAttribution=)]

2017-09-16 匿名的东风

请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!WEIXIN0c40331b 2016-07-19 10:07:00 发表:
第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧.

WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧.

603 0

[GetPortalCommentsPageByObjectIdResponse(id=554361, encodeId=942c554361c2, content=谢谢你老师.已经>30了.估计快了匿名的东风 2018-03-22 发表:: 一审大概30天左右匿名的东风 2018-03-22 00:00:00 发表: 一审大概30天左右, beContent=匿名的东风 2018-03-22 发表:: 一审大概30天左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Sat Mar 31 00:00:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554042, encodeId=2fc8554042e0, content=一审大概30天左右Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, beContent=Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Thu Mar 22 00:00:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552630, encodeId=3013552630cd, content=一审快不快?怕抢发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547260, encodeId=a37f54e26079, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, beContent=alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547259, encodeId=e0c154e259bf, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., beContent=WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546379, encodeId=1e545463e9d6, content=收费吗?怎么个收费原则?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Wed Sep 06 09:08:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538033, encodeId=4e315380339c, content=13.16 血液病还是这个是标杆，没有开源杂志抢稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71a098094, createdName=qsqsqsqs12, createdTime=Fri Jun 16 00:37:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835346, encodeId=13f183534695, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：美国血液学会发表的医学周刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee5414068, createdName=ms7442275544109079, createdTime=Fri Jan 20 10:36:08 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529215, encodeId=55f352921539, content=11.3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Fri Nov 11 10:28:00 CST 2016, time=2016-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834476, encodeId=54bb8344e626, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：录用率那么低的，每次投稿还要交50美金审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Mon Nov 07 09:31:52 CST 2016, time=2016-11-07, status=1, ipAttribution=)]

2017-09-06 lietome24

收费吗?怎么个收费原则?

527 0

[GetPortalCommentsPageByObjectIdResponse(id=554361, encodeId=942c554361c2, content=谢谢你老师.已经>30了.估计快了匿名的东风 2018-03-22 发表:: 一审大概30天左右匿名的东风 2018-03-22 00:00:00 发表: 一审大概30天左右, beContent=匿名的东风 2018-03-22 发表:: 一审大概30天左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Sat Mar 31 00:00:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554042, encodeId=2fc8554042e0, content=一审大概30天左右Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, beContent=Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Thu Mar 22 00:00:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552630, encodeId=3013552630cd, content=一审快不快?怕抢发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547260, encodeId=a37f54e26079, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, beContent=alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547259, encodeId=e0c154e259bf, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., beContent=WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546379, encodeId=1e545463e9d6, content=收费吗?怎么个收费原则?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Wed Sep 06 09:08:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538033, encodeId=4e315380339c, content=13.16 血液病还是这个是标杆，没有开源杂志抢稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71a098094, createdName=qsqsqsqs12, createdTime=Fri Jun 16 00:37:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835346, encodeId=13f183534695, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：美国血液学会发表的医学周刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee5414068, createdName=ms7442275544109079, createdTime=Fri Jan 20 10:36:08 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529215, encodeId=55f352921539, content=11.3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Fri Nov 11 10:28:00 CST 2016, time=2016-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834476, encodeId=54bb8344e626, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：录用率那么低的，每次投稿还要交50美金审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Mon Nov 07 09:31:52 CST 2016, time=2016-11-07, status=1, ipAttribution=)]

2017-06-16 qsqsqsqs12

13.16 血液病还是这个是标杆，没有开源杂志抢稿件

439 0

[GetPortalCommentsPageByObjectIdResponse(id=554361, encodeId=942c554361c2, content=谢谢你老师.已经>30了.估计快了匿名的东风 2018-03-22 发表:: 一审大概30天左右匿名的东风 2018-03-22 00:00:00 发表: 一审大概30天左右, beContent=匿名的东风 2018-03-22 发表:: 一审大概30天左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Sat Mar 31 00:00:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554042, encodeId=2fc8554042e0, content=一审大概30天左右Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, beContent=Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Thu Mar 22 00:00:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552630, encodeId=3013552630cd, content=一审快不快?怕抢发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547260, encodeId=a37f54e26079, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, beContent=alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547259, encodeId=e0c154e259bf, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., beContent=WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546379, encodeId=1e545463e9d6, content=收费吗?怎么个收费原则?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Wed Sep 06 09:08:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538033, encodeId=4e315380339c, content=13.16 血液病还是这个是标杆，没有开源杂志抢稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71a098094, createdName=qsqsqsqs12, createdTime=Fri Jun 16 00:37:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835346, encodeId=13f183534695, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：美国血液学会发表的医学周刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee5414068, createdName=ms7442275544109079, createdTime=Fri Jan 20 10:36:08 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529215, encodeId=55f352921539, content=11.3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Fri Nov 11 10:28:00 CST 2016, time=2016-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834476, encodeId=54bb8344e626, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：录用率那么低的，每次投稿还要交50美金审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Mon Nov 07 09:31:52 CST 2016, time=2016-11-07, status=1, ipAttribution=)]

2017-01-20 ms7442275544109079

审稿速度:1.0 | 投稿命中率:5.0
经验分享：美国血液学会发表的医学周刊。

58 0

[GetPortalCommentsPageByObjectIdResponse(id=554361, encodeId=942c554361c2, content=谢谢你老师.已经>30了.估计快了匿名的东风 2018-03-22 发表:: 一审大概30天左右匿名的东风 2018-03-22 00:00:00 发表: 一审大概30天左右, beContent=匿名的东风 2018-03-22 发表:: 一审大概30天左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Sat Mar 31 00:00:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554042, encodeId=2fc8554042e0, content=一审大概30天左右Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, beContent=Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Thu Mar 22 00:00:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552630, encodeId=3013552630cd, content=一审快不快?怕抢发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547260, encodeId=a37f54e26079, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, beContent=alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547259, encodeId=e0c154e259bf, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., beContent=WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546379, encodeId=1e545463e9d6, content=收费吗?怎么个收费原则?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Wed Sep 06 09:08:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538033, encodeId=4e315380339c, content=13.16 血液病还是这个是标杆，没有开源杂志抢稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71a098094, createdName=qsqsqsqs12, createdTime=Fri Jun 16 00:37:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835346, encodeId=13f183534695, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：美国血液学会发表的医学周刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee5414068, createdName=ms7442275544109079, createdTime=Fri Jan 20 10:36:08 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529215, encodeId=55f352921539, content=11.3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Fri Nov 11 10:28:00 CST 2016, time=2016-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834476, encodeId=54bb8344e626, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：录用率那么低的，每次投稿还要交50美金审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Mon Nov 07 09:31:52 CST 2016, time=2016-11-07, status=1, ipAttribution=)]

2016-11-11 镱鉎鉌釚

11.3

522 0

[GetPortalCommentsPageByObjectIdResponse(id=554361, encodeId=942c554361c2, content=谢谢你老师.已经>30了.估计快了匿名的东风 2018-03-22 发表:: 一审大概30天左右匿名的东风 2018-03-22 00:00:00 发表: 一审大概30天左右, beContent=匿名的东风 2018-03-22 发表:: 一审大概30天左右, objectType=tool_impact_factor, channel=null, level=null, likeNumber=466, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Sat Mar 31 00:00:00 CST 2018, time=2018-03-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=554042, encodeId=2fc8554042e0, content=一审大概30天左右Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, beContent=Dr. H 2018-02-12 00:00:00 发表: 一审快不快?怕抢发, objectType=tool_impact_factor, channel=null, level=null, likeNumber=421, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Thu Mar 22 00:00:00 CST 2018, time=2018-03-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552630, encodeId=3013552630cd, content=一审快不快?怕抢发, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=557, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20170224/IMG58AFD85BAD0444153.jpg, createdBy=25412017681, createdName=Dr. H, createdTime=Mon Feb 12 00:00:00 CST 2018, time=2018-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547260, encodeId=a37f54e26079, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, beContent=alansb 2012-08-26 08:00:00 发表: 今年文章第一次投BLOOD. 只是试一试而已. 侥幸通过. 两位评审还比较NICE. 没有提出多少补充实验...文章要求数据很牢靠. 总结了前十几年在自己研究领域课题的争议. 提出自己的观点给予验证.实验结果不仅需要现象. 还要机制说明. 给大家参考一下自己投稿的时间! Submission date: 22 Mar 2012 Major Revision: 7 May 2012 Revision received: 12 Jul 2012 Minor Revision: 14 Aug 2012 Revision received: 20 Aug 2012 Accepted: 24 Aug 2012 谢谢对大家的支持和努力!再接再厉做好科研!, objectType=tool_impact_factor, channel=null, level=null, likeNumber=480, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=547259, encodeId=e0c154e259bf, content=请问前辈您当时投稿一审修回之后修回的文章还要返回reviewer那里么?还是说编辑审一审就可以决定是否接收了? 多谢前辈!WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., beContent=WEIXIN0c40331b 2016-07-19 10:07:00 发表: 第一次文章投稿blood,很幸运.投稿后34天收到一审回复.建议大修.补了不少实验.第二次审稿20天左右.顺利接受.还被推荐为cover paper.第二次文章.我也做的呕心沥血.结果投了blood,一个星期内就秒据; associate editor都没有送外审.说外审率不超过20%; 后来投到leukemia也悲剧.最后还是历经艰辛.终被hametologica接受.第二次投稿再也没有第一次投稿那么幸运了1!!blood命中率估计10%不到吧., objectType=tool_impact_factor, channel=null, level=null, likeNumber=603, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/03/b1a3d8b1b5258ebd6a5b59ee8bbf0465.jpg, createdBy=2c1c1740830, createdName=匿名的东风, createdTime=Sat Sep 16 00:00:00 CST 2017, time=2017-09-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=546379, encodeId=1e545463e9d6, content=收费吗?怎么个收费原则?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=527, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb131638261, createdName=lietome24, createdTime=Wed Sep 06 09:08:00 CST 2017, time=2017-09-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538033, encodeId=4e315380339c, content=13.16 血液病还是这个是标杆，没有开源杂志抢稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=439, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=71a098094, createdName=qsqsqsqs12, createdTime=Fri Jun 16 00:37:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=835346, encodeId=13f183534695, content=审稿速度:1.0 | 投稿命中率:5.0 经验分享：美国血液学会发表的医学周刊。 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5cee5414068, createdName=ms7442275544109079, createdTime=Fri Jan 20 10:36:08 CST 2017, time=2017-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=529215, encodeId=55f352921539, content=11.3, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=522, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cacheapi.medsci.cn/resource/upload/20160903/IMG57CA05C7ADAC62159.jpg, createdBy=ea6c1943408, createdName=镱鉎鉌釚, createdTime=Fri Nov 11 10:28:00 CST 2016, time=2016-11-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=834476, encodeId=54bb8344e626, content=审稿速度:2.0 | 投稿命中率:50.0 经验分享：录用率那么低的，每次投稿还要交50美金审稿费 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=069a5414125, createdName=ms6134842258072312, createdTime=Mon Nov 07 09:31:52 CST 2016, time=2016-11-07, status=1, ipAttribution=)]

2016-11-07 ms6134842258072312

审稿速度:2.0 | 投稿命中率:50.0
经验分享：录用率那么低的，每次投稿还要交50美金审稿费

54 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务